Form 4: UHS CFO Steve Filton Granted Restricted Stock Units

Universal Health Services' CFO, Steve Filton, was granted 6,850 restricted stock units as part of the company's incentive plan.

Summary

• Steve Filton, Executive Vice President & CFO of Universal Health Services, Inc. (UHS), was granted 6,850 Class B Common Stock restricted stock units.
• The grant occurred on March 26, 2026, with an acquisition price of $0 per unit.
• These units were granted pursuant to the Universal Health Services, Inc. Amended and Restated 2020 Omnibus Stock and Incentive Plan.
• The restricted stock units will vest ratably over four years, on March 26, 2027, March 26, 2028, March 26, 2029, and March 26, 2030.
• Following this transaction, Mr. Filton directly beneficially owns 144,715 Class B Common Stock units.
• Indirect beneficial ownership remains 80,500 units each through The Betsy H. Filton 2020 Irrevocable Trust and The Steve G. Filton 2020 Irrevocable Trust.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive incentive practices that align management's interests with long-term shareholder value.

Positives

• The grant of 6,850 restricted stock units to the CFO aligns management's interests with shareholder value creation.
• The $0 acquisition price indicates these are incentive-based awards, typically tied to performance or retention.

Future Outlook

The vesting schedule for the restricted stock units over the next four years indicates a long-term incentive structure designed to retain key management and align their interests with future company performance.

Industry Context

StockSavvy.ai notes that grants of restricted stock units are a common practice in the healthcare services industry to incentivize and retain senior executives, aligning their long-term interests with shareholder value. This practice is consistent with compensation strategies observed across publicly traded healthcare providers.

Comparison to Industry Standards

• Grants of restricted stock units to executive officers are a standard component of executive compensation packages across various industries, including healthcare.
• Companies like HCA Healthcare (HCA) and Tenet Healthcare (THC) frequently utilize similar equity-based incentives to attract and retain top talent, ensuring management's commitment to long-term strategic goals and financial performance.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of executive interests with long-term company performance.
• Management: Positive impact through increased equity ownership and long-term incentives.

Next Steps

• Vesting of restricted stock units on March 26, 2027.
• Vesting of restricted stock units on March 26, 2028.
• Vesting of restricted stock units on March 26, 2029.
• Vesting of restricted stock units on March 26, 2030.

Key Dates

Recommendation

This Form 4 reports a routine grant of restricted stock units to a key executive, which is a standard component of executive compensation. While it aligns management's interests with shareholders, it does not present new information significant enough to alter an investment thesis or recommendation for Universal Health Services (UHS) at this time.

Keywords

Universal Health Services, UHS, Steve Filton, Restricted Stock Units, RSU, Executive Compensation, SEC Form 4, Insider Transaction, Stock Grant, Healthcare Services